Observational studyJournal for immunotherapy of cancer2021

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.

Fangwen Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.